patent/US-6248365-B1

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6248365-B1

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74fa5a9700ef5f525e1b6f75b4e30e6b
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4873 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
filingDate	1993-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate	2001-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb30e5c617fa3f35f8c75a651f525bb3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4243e2a883bad9dd171e59c430f6c4d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99f59c120f015822db64d50bd0253caf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed3c5a7325964e2d2de629ef5b7d6ec4
publicationDate	2001-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	US-6248365-B1
titleOfInvention	Use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura
abstract	The invention relates to the use of complement inhibitors, especially of C1 inactivator or of factors I or H, for the preparation of a pharmaceutical and for the prophylaxis and therapy of chronic inflammatory intestinal disorders, inflammatory skin disorders and purpura.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007224197-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10532087-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010143344-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007020647-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006292141-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9096677-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008102040-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008299114-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8007804-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10441631-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8858945-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013041677-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9259488-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2928460-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8088579-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8497350-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008267980-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10286047-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7745389-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018024873-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014207199-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9650447-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11554156-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7964705-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011113641-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018037046-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11168120-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7999082-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10471142-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11191851-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10239937-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9212212-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016196070-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022109124-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9803005-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7759304-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8911733-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE49339-E http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011165232-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8465737-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009247451-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8569225-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004038925-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11000577-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013093027-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9283220-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019055763-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8540997-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8323670-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011082167-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10973891-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012078968-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007196367-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9066925-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8703140-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010032073-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009124542-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008075720-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8652475-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9815890-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010086581-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8703136-B2
priorityDate	1992-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4981855-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4915945-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5135916-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5166134-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9210205-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0222611-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5157019-A
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128812924 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5755 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395467 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395468 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11245343

Total number of triples: 104.